Geneart Posts 28 Percent Revenue Growth for 2008 | GenomeWeb

NEW YORK (GenomeWeb News) – Geneart today released preliminary figures for its fiscal year 2008, showing a 28 percent jump in revenues to €15.7 million ($20.1 million) from €12.3 million.

The German gene synthesis firm had earnings before interest and taxes of €800,000, down from €1.8 million in 2007. It said that its profit was affected by one-time expenses associated with depreciations on inventories due to lower production costs and negative currency effects related to the US dollar.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.